MONTREAL – Tactio Health Group has registered its TactioRPM telehealth platform at both the Brazilian Health Regulatory Agency (ANVISA) and French National Agency for Medicine and Health Products Safety (ANSM) for CE Mark Class I. This follows TactioRPM’s registration at the U.S. Food and Drug Administration in 2015. TactioRPM is an app-enabled platform that combines mobile apps, hundreds of connected health integrations, patient questionnaires, digital coaching programs and HIPAA-compliant messaging. Powering telehealth initiatives from payers, providers and pharma, its range of clinical applications include chronic disease monitoring, population health screening, clinical research and post-acute care.
You are here: / / Tactio gets ANVISA and CE Mark for telehealth platform